Evaluation of Anti‐atopic Dermatitis Activity of Hypsizigus marmoreus Extract
暂无分享,去创建一个
[1] Hongwei Liu,et al. A new benzoquinone and a new benzofuran from the edible mushroom Neolentinus lepideus and their inhibitory activity in NO production inhibition assay. , 2013, Food chemistry.
[2] T. Zuberbier,et al. The role of interleukin-1 in allergy-related disorders , 2012, Current opinion in allergy and clinical immunology.
[3] D. Parsad,et al. The effect of topically applied corticosteroids on interleukin 1β levels in patients with atopic dermatitis , 2012, Journal of the European Academy of Dermatology and Venereology.
[4] M. Akiyama,et al. A group of atopic dermatitis without IgE elevation or barrier impairment shows a high Th1 frequency: possible immunological state of the intrinsic type. , 2012, Journal of dermatological science.
[5] S. You,et al. Molecular Properties of Water-Unextractable Proteoglycans from Hypsizygus marmoreus and Their in Vitro Immunomodulatory Activities , 2011, Molecules.
[6] Lei Cheng,et al. [Allergen-specific immunotherapy: current concepts and future directions]. , 2011, Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery.
[7] M. Ohnishi,et al. Profiling of hepatic gene expression of mice fed with edible japanese mushrooms by DNA microarray analysis: comparison among Pleurotus ostreatus, Grifola frondosa, and Hypsizigus marmoreus. , 2011, Journal of agricultural and food chemistry.
[8] J. Simon,et al. Anti-inflammatory activity of edible oyster mushroom is mediated through the inhibition of NF-κB and AP-1 signaling , 2011, Nutrition journal.
[9] T. Ng,et al. Marmorin, a new ribosome inactivating protein with antiproliferative and HIV-1 reverse transcriptase inhibitory activities from the mushroom Hypsizigus marmoreus , 2008, Applied Microbiology and Biotechnology.
[10] A. Watanabe,et al. Preventive effects of edible mushroom (Hypsizigus marmoreus) on mouse type IV allergy: fluctuations of cytokine levels and antioxidant activities in mouse sera. , 2008, Journal of food science.
[11] A. Flahault,et al. Corticosteroid-Induced Adverse Events in Adults , 2007, Drug safety.
[12] K. Yasui,et al. A novel atopic dermatitis model induced by topical application with dermatophagoides farinae extract in NC/Nga mice. , 2007, Allergology international : official journal of the Japanese Society of Allergology.
[13] Y. Tomimori,et al. Repeated topical challenge with chemical antigen elicits sustained dermatitis in NC/Nga mice in specific-pathogen-free condition. , 2005, The Journal of investigative dermatology.
[14] Donald Y M Leung,et al. Amendment history : Erratum ( April 2004 ) New insights into atopic dermatitis , 2018 .
[15] H. Mizutani,et al. Animal Models of Atopic Dermatitis , 2004 .
[16] T. Ng,et al. Hypsin, a novel thermostable ribosome-inactivating protein with antifungal and antiproliferative activities from fruiting bodies of the edible mushroom Hypsizigus marmoreus. , 2001, Biochemical and biophysical research communications.
[17] P. Calder,et al. Dietary fish oil reduces intercellular adhesion molecule 1 and scavenger receptor expression on murine macrophages. , 2000, Atherosclerosis.
[18] C. Dinarello,et al. Proinflammatory cytokines. , 2000, Chest.
[19] S. Opal,et al. Anti-inflammatory cytokines. , 2000, Chest.
[20] T. Irimura,et al. Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. , 1999, The Journal of clinical investigation.
[21] C. Bruijnzeel-Koomen,et al. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. , 1998, Immunology today.
[22] H. Nakagawa,et al. Chronologic analysis of in situ cytokine expression in mite allergen-induced dermatitis in atopic subjects. , 1995, The Journal of allergy and clinical immunology.
[23] Peng Wang,et al. Interleukin (IL)-10 Inhibits Nuclear Factor B (NFB) Activation in Human Monocytes , 1995, The Journal of Biological Chemistry.
[24] M. Billah,et al. Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. , 1995, The Journal of biological chemistry.
[25] Q. Hamid,et al. Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. , 1994, The Journal of clinical investigation.
[26] C. Dinarello,et al. Coordinated antiinflammatory effects of interleukin 4: interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[27] C. Figdor,et al. Interleukin-4 (IL-4) inhibits secretion of IL-1 beta, tumor necrosis factor alpha, and IL-6 by human monocytes. , 1990, Blood.
[28] I I Lelis,et al. [Atopic dermatitis]. , 1980, Vestnik dermatologii i venerologii.